Sitemap - 2025 - The California Stem Cell Report

National Research Funding Turmoil and California's Stem Cell Agency's Sustainability

Capricor Says CIRM-Backed Therapy is 'Well Postioned' to Move Forward to Clinical Use

California's Half-Billion Dollars for Stem Cell/Gene Therapy Research, Plus a Not-So-Secret Sauce for Greater Impact

Capricor, the FDA and Millions from the State of California

Waning Financial Enthusiasm for Gene Therapies: National Picture is Bleak, Says Barron's

Sarepta's Stock Sinks Sharply Following News of Second Death Involving Genetic Therapy

Second Death in Gene Therapy Trial for a Rare Muscle Degenerative Disorder

Who are the Big Winners of California's Billions for Stem Cell and Gene Therapy Research?

Easing of Regulation of Unproven Stem Cell Therapies Looming; RFK Jr. Discloses His Treatment

California's Stem Cell/Gene Therapy Budget to Hit All-Time High of More than $500 Million

California Gene Therapy Program Expresses Condolences Following Death of Patient in Clinical Trial

Death in Clinical Trial Supported With $5.8 Million From California Stem Cell and Gene Therapy Agency

Pluses and Minuses: How 17,000 Words Shape California's $12 Billion Stem Cell and Gene Therapy Program

Financial Conundrum: Half-a-Billion Dollar Spending Gap in California Stem Cell/Gene Therapy Research

KJ Muldoon Advisory: California's Gene Therapy Research Program Weighs In

Starting Gate at CIRM for $160 Million in Stem Cell and Gene Therapy Research Awards

One in a Million: Speedy Work from Maine to California Leads to Custom Genetic Treatment for Rare Disease

California Effort to Create a State Version of the NIH Stalls; Was Response to Trump Research Turmoil

California and Its Ties to Rare Moms on Mother's Day

Fertile Field for California's Stem Cell/Gene Therapy Story: Can It Measure Up?

From Dragon Building to STAT: A 16-Year Journey into the World of 'Ink-Stained Wretches'

From Market Studies to 'Value' Messaging, California Stem Cell/Gene Therapy Agency Bets Big on Affordability Plan

California's Affordability Plan for Cell/Gene Therapy Could be National Model

California's Stem Cell and Gene Therapy Program Could Take an Indirect Hit from a New Trumpian Order

California's Pathway to the Affordability of Multimillion-Dollar, Revolutionary Stem Cell and Gene Therapies

A Life and Death Matter? The Frustrating 'Non-Image' of California's $12 Billion Gene Therapy/Stem Cell Research Program

Dodging the Politicos and Delivering Billions to Stem Cell and Gene Therapy Research in California

Want to Help Give Away Billions? California's Stem Cell/Gene Therapy Agency Has Posted Openings

The 'Biotech Doom Loop,' Paralysis and Exhaustion

Who Is Going to Benefit from California's New Stem Cell/Gene Research Priorities?

A CIRM Sibling is Gestating in the California Legislature

Paying for Multimillion-Dollar Therapies: A Look at Some Models this Friday

California's Stem Cell/Gene Therapy Agency, a Man Named Marks and the Future

California Launches $429 Million in New Stem Cell/Gene Therapy Plans, Striving for Bigger Impact plus Speeding Commercialization

Reaction to Trump: California Legislation to Create a State Version of the NIH

Late Changes in California Stem Cell/Gene Therapy Award Proposals; Hundreds of Millions of Dollars Involved

Timely CIRM Posting of Explanations, Rationale for Big Changes in California's Stem Cell/Gene Therapy Program

Trump Cuts Trigger Hiring Freeze and Other Reductions at the University of California

Trump and the California Stem Cell/Gene Therapy Program: 'Resolute' Response Publicly, Concern About How to Tell the Story

Want to Help Give Away Billions? California's Gene Therapy and Stem Cell Research Agency is Looking for Assistance

No Plans by California Stem Cell/Gene Therapy Agency to Help State Researchers with Trump Cutbacks

$36 Million California Plan Moves Forward to Boost Patients into Stem Cell/Gene Therapy Trials

This is Not a Stem Cell Item

Trump Cuts in NIH Research Funding Remain on Legal Hold

$429 Million Stem Cell/Genetic Research Plan Advances Today in California; Supporters Promise High Impact

China Targets San Diego's Illumina in Retaliation for Trump Tariffs Increase

$429 Million Stem Cell/Gene Research Plan: New 'Preferences' for Determining Awards From California Agency

California Proposing $429 Million For Stem Cell and Gene Therapy Research; Almost Certain to be Approved

Want to Help Giving Away Billions? The California Stem Cell/Gene Therapy Agency is Looking for You

The Atlantic Magazine Goes 'Inside the Collapse at the NIH'

A 'Position of Luxury,' CIRM's 'Angel Investors' and the Media

How Long Can the Billions Last? Trump Cuts and New Priorities Could Pressure California Stem Cell/Gene Therapy Program

New York Times: NIH Grant Application Review Sessions Halted; Unclear If or When They Will Resume

Federal Cuts in Research Stayed Again, But Trump Actions to Evade Court Orders are Surfacing

Critical Hearing Tomorrow on Trump Research Cuts, Potentially $5 Billion Nationally and $800 Million in California

Trumpian Vagaries and California Researchers: A Potential $800 Million Financial Whack

NIH Research Lagging by $1 Billion, Plus State by State and Leading Institutions Rundown Involving Overhead Cuts

California Would Suffer $800 Million Hit Under Trump Research Cuts

Judge Says No to Trump Research Cuts, at Least Temporarily

Trump's Cuts to Scientific Research, California's Multibillion-Dollar Research Agency and the Role It Could Play

A Mother's Plea, a Fearsome Genetic Affliction and Rejection by California's Gene Therapy Research Agency

A $17 Million Question: How Do Tiny Smog Particles from Wildfires Infiltrate Your Brain and Do Their Nasty Business?

California's 19 Research Winners: A $100 Million Contrast to the National Biomedical Scene

No Research Funding Cancellation for the Golden State; $100 Million Went Out the Door This Week

Update: Federal Research Funding May Be Safe

Tuesday Morning Update on the Trumpian Orders on Research Grants, DEI, Etc.

Fraud and Misconduct in Alzheimer's Research: New Book Dives into the "Legacy of Lies"

Trump Administration Squeeze on New NIH Research Awards; Peer Review of Applications Halted

CIRM's Directors, Sustainability of the Enterprise and Performance Reviews

From the Pacific Ocean to the City of Hope, a Tale of Destruction, Fire and Science

This is Not a Stem Cell Item

FDA and California's $12 Billion CIRM: Aligning Development of Rare Disease Research?

Looking for Work? Want to Tout Revolutionary Stem Cell and Gene Therapy Research?

Correction

Three Month Road Map: California to Beef Up Impact of Billions for Stem Cell and Gene Therapy Research

Stem Cells, Knees and Dubious Clinics: UC Davis Researcher Says 'Most Often a Waste'